Literature DB >> 3103482

Isolation and the fluorometric, high-performance liquid chromatographic determination of tacrine.

T H Park, K H Tachiki, W K Summers, D Kling, J Fitten, K Perryman, K Spidell, A S Kling.   

Abstract

Tacrine (THA; 1,2,3,4-tetrahydro-9-aminoacridine) is an anticholinesterase agent which has been used clinically, most recently in the treatment of Alzheimer-type dementias. This paper describes the methodology for the isolation and quantitation of THA at therapeutic levels in serum from human subjects. Using C18 Bond Elut columns and an HPLC/fluorometry system, this assay exhibits a considerable improvement in sensitivity over previous uv methods, and allows routine testing of THA levels in serum samples of reasonable volume from human subjects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3103482     DOI: 10.1016/0003-2697(86)90353-2

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Bioavailability and pharmacokinetic disposition of tacrine in elderly patients with Alzheimer's disease.

Authors:  G Lou; P R Montgomery; D S Sitar
Journal:  J Psychiatry Neurosci       Date:  1996-11       Impact factor: 6.186

2.  Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride.

Authors:  Rashmi S Upasani; Ajay K Banga
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

3.  Clinical pharmacokinetics of intravenous and oral 9-amino-1,2,3,4-tetrahydroacridine, tacrine.

Authors:  P Hartvig; H Askmark; S M Aquilonius; L Wiklund; B Lindström
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.

Authors:  P B Clarke; M Reuben; H el-Bizri
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.